148 related articles for article (PubMed ID: 26776229)
1. Diagnosis of an additional in situ melanoma does not influence survival for patients with a single invasive melanoma: A registry-based follow-up study.
Youlden DR; Khosrotehrani K; Green AC; Soyer HP; Kimlin MG; Youl PH; Aitken JF; Baade PD
Australas J Dermatol; 2016 Feb; 57(1):57-60. PubMed ID: 26776229
[TBL] [Abstract][Full Text] [Related]
2. Survival outcomes in patients with multiple primary melanomas.
Rowe CJ; Law MH; Palmer JM; MacGregor S; Hayward NK; Khosrotehrani K
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2120-7. PubMed ID: 25864459
[TBL] [Abstract][Full Text] [Related]
3. Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia.
Green AC; Baade P; Coory M; Aitken JF; Smithers M
J Clin Oncol; 2012 May; 30(13):1462-7. PubMed ID: 22412152
[TBL] [Abstract][Full Text] [Related]
4. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
[TBL] [Abstract][Full Text] [Related]
5. Prognostic importance of a second invasive primary melanoma according to tumour stage.
Youlden DR; Baade PD; Aitken JF; Green AC; Khosrotehrani K
Br J Dermatol; 2017 Dec; 177(6):e336-e337. PubMed ID: 28771669
[No Abstract] [Full Text] [Related]
6. Ten-Year Survival after Multiple Invasive Melanomas Is Worse than after a Single Melanoma: a Population-Based Study.
Youlden DR; Baade PD; Soyer HP; Youl PH; Kimlin MG; Aitken JF; Green AC; Khosrotehrani K
J Invest Dermatol; 2016 Nov; 136(11):2270-2276. PubMed ID: 27019458
[TBL] [Abstract][Full Text] [Related]
7. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.
Coory M; Baade P; Aitken J; Smithers M; McLeod GR; Ring I
Cancer Causes Control; 2006 Feb; 17(1):21-7. PubMed ID: 16411049
[TBL] [Abstract][Full Text] [Related]
8. Melanoma survival is superior in females across all tumour stages but is influenced by age.
Khosrotehrani K; Dasgupta P; Byrom L; Youlden DR; Baade PD; Green AC
Arch Dermatol Res; 2015 Oct; 307(8):731-40. PubMed ID: 26103951
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
[TBL] [Abstract][Full Text] [Related]
10. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register.
Lyth J; Hansson J; Ingvar C; Månsson-Brahme E; Naredi P; Stierner U; Wagenius G; Lindholm C;
Br J Dermatol; 2013 Apr; 168(4):779-86. PubMed ID: 23066913
[TBL] [Abstract][Full Text] [Related]
11. Melanoma survival disadvantage in young, non-Hispanic white males compared with females.
Gamba CS; Clarke CA; Keegan TH; Tao L; Swetter SM
JAMA Dermatol; 2013 Aug; 149(8):912-20. PubMed ID: 23804160
[TBL] [Abstract][Full Text] [Related]
12. A population-based validation of the American Joint Committee on Cancer melanoma staging system.
Gimotty PA; Botbyl J; Soong SJ; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8065-75. PubMed ID: 16258105
[TBL] [Abstract][Full Text] [Related]
13. Opportunistic screening strategy for cutaneous melanoma does not change the incidence of nodular and thick lesions nor reduce mortality: a population-based descriptive study in the European region with the highest incidence.
Bordoni A; Leoni-Parvex S; Peverelli S; Mazzola P; Mazzucchelli L; Spitale A
Melanoma Res; 2013 Oct; 23(5):402-7. PubMed ID: 23839077
[TBL] [Abstract][Full Text] [Related]
14. National utilization patterns of Mohs micrographic surgery for invasive melanoma and melanoma in situ.
Viola KV; Rezzadeh KS; Gonsalves L; Patel P; Gross CP; Yoo J; Stamell E; Turner RB
J Am Acad Dermatol; 2015 Jun; 72(6):1060-5. PubMed ID: 25824274
[TBL] [Abstract][Full Text] [Related]
15. Risk of second primary in situ and invasive melanoma in a Dutch population-based cohort: 1989-2008.
van der Leest RJ; Liu L; Coebergh JW; Neumann HA; Mooi WJ; Nijsten T; de Vries E
Br J Dermatol; 2012 Dec; 167(6):1321-30. PubMed ID: 22759226
[TBL] [Abstract][Full Text] [Related]
16. Characteristics, treatment, and survival of invasive malignant melanoma (MM) in giant pigmented nevi (GPN) in adults: 976 cases from the National Cancer Data Base (NCDB).
Turkeltaub AE; Pezzi TA; Pezzi CM; Dao H
J Am Acad Dermatol; 2016 Jun; 74(6):1128-34. PubMed ID: 26899200
[TBL] [Abstract][Full Text] [Related]
17. Second Primary Melanoma: Risk Factors, Histopathologic Features, Survival, and Implications for Follow-Up.
Jones MS; Torisu-Itakura H; Flaherty DC; Schoellhammer HF; Lee J; Sim MS; Faries MB
Am Surg; 2016 Oct; 82(10):1009-1013. PubMed ID: 27779995
[TBL] [Abstract][Full Text] [Related]
18. The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past.
Crocetti E; Caldarella A; Chiarugi A; Nardini P; Zappa M
Melanoma Res; 2010 Oct; 20(5):422-6. PubMed ID: 20679908
[TBL] [Abstract][Full Text] [Related]
19. Competing risk analysis of mortality from invasive cutaneous melanoma in New South Wales: a population-based study, 1988-2007.
Marashi-Pour S; Morrell S; Cooke-Yarborough C; Arcorace M; Baker D
Aust N Z J Public Health; 2012 Oct; 36(5):441-5. PubMed ID: 23025365
[TBL] [Abstract][Full Text] [Related]
20. The incidence of second primary invasive melanoma in Queensland, 1982-2003.
McCaul KA; Fritschi L; Baade P; Coory M
Cancer Causes Control; 2008 Jun; 19(5):451-8. PubMed ID: 18167620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
